Table 3.

Possible Associations between Either Periostin or NLR and Stroke Severity in the Patient Group.

Factors Periostin NLR

Correlation Coefficient P Correlation Coefficient P
NIHSS (at admission) 0.055 0.729 0.307 0.048

NIHSS (at 7th day) −0.150 0.342 0.281 0.072

mRS (at admission) 0.090 0.572 0.236 0.132

mRS (at 7th day) −0.115 0.469 0.315 0.042

Factors Median Periostin, ng/ml [range] P Median NLR [range] P

Comorbidity
 None 3.88 [1.56–9.4] 0.731 3.6 [1.65–14.3] 0.448
 HT 3.12 [1.19–7.18] 3.41 [2.21–19.13]
 DM 2.94 [1.58–6.26] 2.95 [1.29–4.49]
 HT+DM 2.87 [1.42–7.41] 2.52 [1.25–20.3]

Bamford classification
 TACI 6.51 [1.97–9.4] 0.514 4.42 [3.46–20.3] 0.500
 PACI 3.12 [1.42–7.41] 3.5 [1.25–19.13]
 POCI 2.75 [1.19–5.44] 2.61 [1.65–14.3]
 LACI 3.26 [1.56–9.13] 3.43 [1.29–7.37]

DM, diabetes mellitus; HT, hypertension; LACI, lacunar infarcts; mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Scale; PACI, partial anterior circulation infarcts; POCI, posterior circulation infarction; TACI, total anterior circulation infarcts.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2021 July; 12(3): e0021. ISSN: 2076-9172
Published online 2021 July 20. doi: 10.5041/RMMJ.10440.